Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumor DNA predicts venous thromboembolism in patients with cancers.

Journal of thrombosis and haemostasis : JTH - 1 Jan 2025

Ma Shengling, Jiang Jun Yang, Kim Rock Bum, Chiang Elizabeth, Theng Tiong Joyce Wan, Ryu Justine, Guffey Danielle, Bandyo Raka, Dowst Heidi, Swinnerton Kaitlin N, Fillmore Nathanael R, La Jennifer, Li Ang

Abstract excerpt

BACKGROUND: Despite rapid advances in liquid biopsy for circulating tumor DNA (ctDNA), its prognostic value for venous thromboembolism (VTE) in patients with cancer is underexplored, particularly in underserved and minoritized populations. OBJECTIVES: To evaluate the role of ctDNA in risk stratification for cancer-associated VTE. METHODS: We analyzed data from 1038 cancer patients who underwent ctDNA measurement...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liquid Biopsy

Share to Neoplasms

Share to Predictive Value of Tests

Share to Risk Assessment

Share to United States

Share to Venous Thromboembolism

Source

Open in PubMed Open full text

Identifiers

PMID: 39341370
DOI: 10.1016/j.jtha.2024.09.009
PMCID: PMC12045112

Genes

CDKN2A
EGFR
KRAS
NF1
PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating tumor DNA predicts venous thromboembolism in patients with cancers.PMID 39341370Read ↗

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors.Semantic proximity Read ↗

Potential utility of comprehensive genomic profiling to predict venous thromboembolism in patients with solid cancer.Semantic proximity Read ↗

Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer.Semantic proximity Read ↗

Genomic Profiling Identifies Somatic Mutations Predicting Thromboembolic Risk in Patients with Solid TumorsSemantic proximity Read ↗

Associations of tumor somatic mutations with cancer-associated venous thromboembolism.Semantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Circulating tumor DNA to predict the risk of venous thromboembolism in locally advanced rectal cancer.Semantic proximity Read ↗

Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort studySemantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

Associations of tumour somatic mutations with cancer-associated venous thromboembolismSemantic proximity Read ↗

Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.Semantic proximity Read ↗

Association between tumour somatic mutations and venous thromboembolism in the 100,000 Genomes Project cancer cohort: a study protocolSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.